BioMedNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Reports Q3 Financials, Highlights Growth from Progressive Care and Outfitter Satellite Acquisitions

NextPlat (NASDAQ: NXPL, NXPLW)  reported Q3 2024 results reflecting the impact of its recent acquisitions, including Progressive Care and Outfitter Satellite, which contributed to consolidated revenues of $15.4 million. While healthcare revenue declined due to lower prescription reimbursement rates, e-Commerce revenue saw a 31% increase, largely from the Outfitter acquisition. The company recorded a net loss of $4.2 million due to increased expenses, including a non-cash impairment of Progressive Care’s intangible assets. Recent developments include expanding healthcare contracts and satellite communication device sales, along with a strengthened e-commerce presence in China and the UK. NextPlat projects ongoing growth from integration efficiencies and increased global demand in its healthcare and e-commerce sectors.

To view the full press release, visit: https://ibn.fm/XqDXq

About NextPlat Corp

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company intends to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc.

NOTE TO INVESTORS: The latest news and updates relating to NXPL are available in the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN